Ascendis Pharma A/S (ASND) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 6-K | — | SEC |
| 2026-08-13 | 6-K | — | SEC |
| 2026-08-12 | 6-K | — | SEC |
| 2026-08-06 | 6-K | — | SEC |
| 2026-07-15 | 6-K | — | SEC |
| 2026-06-30 | 6-K | — | SEC |
| 2026-06-29 | 6-K | — | SEC |
| 2026-06-17 | 6-K | — | SEC |
| 2026-06-15 | 6-K | — | SEC |
| 2026-06-12 | 6-K | — | SEC |
| 2026-06-10 | 6-K | — | SEC |
| 2026-05-13 | 6-K | — | SEC |
| 2026-05-07 | 6-K | — | SEC |
| 2026-05-07 | 6-K | — | SEC |
| 2026-04-21 | 6-K | — | SEC |
| 2026-04-21 | 6-K | — | SEC |
| 2026-04-20 | 6-K | — | SEC |
| 2026-04-16 | 6-K | — | SEC |
| 2026-04-08 | 6-K | — | SEC |
| 2026-04-08 | 6-K | — | SEC |
| 2026-04-07 | 6-K | — | SEC |
| 2026-03-30 | 6-K | — | SEC |
| 2026-03-24 | 6-K | — | SEC |
| 2026-03-17 | 6-K | — | SEC |
| 2026-03-16 | 6-K | — | SEC |
| 2026-03-11 | 6-K | — | SEC |
| 2026-03-02 | 6-K | — | SEC |
| 2026-02-23 | 6-K | — | SEC |
| 2026-02-11 | 6-K | — | SEC |
| 2026-02-11 | 6-K | — | SEC |
| 2026-01-14 | 6-K | — | SEC |
| 2026-01-12 | 6-K | — | SEC |
| 2026-01-09 | 6-K | — | SEC |
| 2025-12-30 | 6-K | — | SEC |
| 2025-12-10 | 6-K | — | SEC |
| 2025-11-26 | 6-K | — | SEC |
| 2025-11-12 | 6-K | — | SEC |
| 2025-11-12 | 6-K | — | SEC |
| 2025-11-12 | 6-K | — | SEC |
| 2025-10-22 | 6-K | — | SEC |
| 2025-10-15 | 6-K | — | SEC |
| 2025-10-08 | 6-K | — | SEC |
| 2025-09-30 | 6-K | — | SEC |
| 2025-09-10 | 6-K | — | SEC |
| 2025-08-13 | 6-K | — | SEC |
| 2025-08-07 | 6-K | — | SEC |
| 2025-08-07 | 6-K | — | SEC |
| 2025-07-28 | 6-K | — | SEC |
| 2025-07-09 | 6-K | — | SEC |
| 2025-06-27 | 6-K | — | SEC |
| 2025-06-11 | 6-K | — | SEC |
| 2025-06-09 | 6-K | — | SEC |
| 2025-06-09 | 6-K | — | SEC |
| 2025-06-02 | 6-K | — | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-14 | 6-K | — | SEC |
| 2025-05-01 | 6-K | — | SEC |
| 2025-05-01 | 6-K | — | SEC |
| 2025-04-29 | 6-K | — | SEC |
| 2025-04-09 | 6-K | — | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.